Search hospitals > South Carolina > Greenville
Prisma Health Cancer Institute - Faris
Claim this profileGreenville, South Carolina 29605
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Adenocarcinoma
Conducts research for Non-Small Cell Lung Cancer
322 reported clinical trials
8 medical researchers
Summary
Prisma Health Cancer Institute - Faris is a medical facility located in Greenville, South Carolina. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Adenocarcinoma, Non-Small Cell Lung Cancer and other specialties. Prisma Health Cancer Institute - Faris is involved with conducting 322 clinical trials across 478 conditions. There are 8 research doctors associated with this hospital, such as Ki Chung, MD, Aniket Saha, Jeffrey K. Giguere, and Michael D. Zurenko.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderStage IV
HER2 negative
ER positive
Top PIs
Ki Chung, MDPrisma Health Cancer Institute - Eastside5 years of reported clinical research
Expert in Cancer
Expert in Tumors
90 reported clinical trials
188 drugs studied
Aniket SahaBI-LO Charities Children's Cancer Center6 years of reported clinical research
Expert in Brain Tumor
Expert in Tumors
57 reported clinical trials
118 drugs studied
Jeffrey K. GiguerePrisma Health Cancer Institute - Faris7 years of reported clinical research
Studies Cancer
Studies Breast Cancer
26 reported clinical trials
64 drugs studied
Michael D. ZurenkoPrisma Health Cancer Institute - Eastside11 years of reported clinical research
Studies Cancer
Studies Prostate Cancer
8 reported clinical trials
16 drugs studied
Clinical Trials running at Prisma Health Cancer Institute - Faris
Breast Cancer
Lung Cancer
Cancer
Non-Small Cell Lung Cancer
Colorectal Cancer
Bladder Cancer
Tumors
Oropharyngeal Carcinoma
Rectal Cancer
Colon Cancer
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This study is evaluating whether a drug used to treat high blood pressure and heart failure may help prevent heart damage in patients with breast cancer.
Recruiting2 awards Phase 323 criteria
Support Program
for Breast Cancer
This study is evaluating whether a support program may help breast cancer patients take their medication correctly.
Recruiting2 awards Phase 34 criteria
Shorter Chemo-Immunotherapy Without Anthracyclines
for Breast Cancer
This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Prisma Health Cancer Institute - Faris?
Prisma Health Cancer Institute - Faris is a medical facility located in Greenville, South Carolina. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Adenocarcinoma, Non-Small Cell Lung Cancer and other specialties. Prisma Health Cancer Institute - Faris is involved with conducting 322 clinical trials across 478 conditions. There are 8 research doctors associated with this hospital, such as Ki Chung, MD, Aniket Saha, Jeffrey K. Giguere, and Michael D. Zurenko.
Where is Prisma Health Cancer Institute - Faris located?
The Prisma Health Cancer Institute - Faris Hospital is located at 900 W. Faris Road, Greenville, SC 29605.
Who should I call to ask about financial aid or insurance network?
For financial assistance and insurance inquiries at Prisma Health Cancer Institute–Faris Road:
- **Financial Assistance**: Visit the Prisma Health financial assistance page for general information.
- **Hospital Patient Accounts**: Call 864-454-9604 or toll-free 1-844-302-8298 for billing and insurance inquiries.
- **Physician Practice Patient Billing**: For billing questions, contact 864-797-6980 or toll-free 1-844-644-3160.
What insurance does Prisma Health Cancer Institute - Faris accept?
The Prisma Health Cancer Institute - Faris accepts a range of insurance plans such as Absolute Total Care - Ambetter, Absolute Total Care Medicaid, Aetna, Aetna Medicare, Allwell Medicare - Absolute Total Care, BCBS, BCBS Blue Cross, and UnitedHealthcare. It is recommended to directly contact the providers or facilities within the Institute to confirm the acceptance of specific insurance plans.
What awards or recognition has Prisma Health Cancer Institute - Faris received?
The Prisma Health Cancer Institute - Faris, located in Greenville, South Carolina, has received an $8.2 million award from the National Cancer Institute for outstanding research contributions through the National Cancer Institute Community Oncology Research Program. This institute is dedicated to the protection of human subjects in research, holding a Federalwide Assurance (FWA).